News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

FDA Approves BioGaia's Request for Orphan Drug Designation


8/6/2013 9:22:53 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Necrotizing enterocolitis (NEC) is a rare and extremely severe disease that affects premature infants. BioGaia is in a very early stage of investigating the possibilities of developing a drug within this field and has submitted a request for orphan drug designation in the USA. The FDA Office of Orphan Product Development has now approved BioGaia’s request.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES